Price increase branded drugs widel used by seniors by manufacturer U.S. 2020

This statistic depicts the average price increase of brand name drugs widely used by older adults in the U.S. during 2020, by manufacturer. Two such drugs manufactured by Gilead Sciences showed an average increase in retail prices of 6.1 percent. Compared to that, Shire US' eight drugs widely used by seniors on average showed a drop of nearly two percent in retail prices.

Average retail price increase of brand name drugs widely used by older adults in the U.S. in 2020, by manufacturer

Manufacturer (number of drugs)	Price increase
Gilead Sciences (2)	6.1%
Bausch Health (11)	5.3%
Boehringer Ingelheim (8)	4.8%
Bristo-Myers Squibb (2)	4.5%
AstraZeneca (16)	4.4%
Purdue Pharma L.P. (6)	4.2%
Novartis (15)	4%
Kowa Pharmaceucticals (2)	4%
Sunovion Pharmaceucticals (5)	4%
Merck Sharp and Dohme (11)	3.8%
Pfizer (20)	3.7%
Allergan (24)	3.5%
Janssen (10)	3.5%
AbbVie (13)	3.3%
UCB Pharma (4)	2.3%
Novo Nordisk (8)	2.1%
Astellas (4)	2.1%
Takeda Pharmaceuticals (7)	1.5%
Amgen (4)	1.5%
GlaxoSmithKline (19)	1.2%
Lilly (12)	0.4%
Sandoz (2)	0.1%
Genentech (2)	0%
Horizon Therapeutics (4)	-0.1%
Sanofi-Aventis (8)	-0.3%
Otsuka America (2)	-0.3%
Shire US (8)	-1.9%

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

Release date

June 2021

More information

Region

United States

Survey time period

2020

Supplementary notes

Note: Calculations of the average annual brand name drug price change include the 260 drug products most widely used by older Americans (see Appendix A). Manufacturers with only 1 drug product in the market basket of 260 most widely used brand name prescription drugs were included in the “All Others” category. The number in parentheses after a manufacturer’s name indicates the number of drug products in the market basket for that manufacturer. The general inflation rate is based on CPI-U All Items for 2020.

Citation formats